S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
about
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
S1501 Carvedilol in Preventing ...... c HER-2-Positive Breast Cancer
@en
type
label
S1501 Carvedilol in Preventing ...... c HER-2-Positive Breast Cancer
@en
prefLabel
S1501 Carvedilol in Preventing ...... c HER-2-Positive Breast Cancer
@en
P6153
P131
P1476
Prospective Evaluation of Carv ...... ER-2+ Breast Cancer, Phase III
@en
P3098
NCT03418961
P4844
P580
2017-09-15T00:00:00Z
P582
2023-02-01T00:00:00Z